gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NYSE · GMEDHealthcareSurgical Instruments

GLOBUS MEDICAL INC (GMED)

$87.10+9.45%
Close Nov 4, 2026 · split-adjusted
Nov 4, 2026$87.10▲ 41.26% in range
Nov 4, 2025Low $61.51 · High $96.82Nov 4, 2026
What changed · written from our data
As of Nov 4, 2026

GLOBUS MEDICAL closed at $87.10 on Nov 4, up 9.45%, 10.0% below its 52-week closing high. Volume of 2.4M shares was 1.79× its 20-day average (above normal).

Split-adjusted performance: +14.0% over one month, -2.4% over six months, +42.3% over one year.

In the quarter ended Jun 30, 2026, revenue was $789.61M, up 5.9% from a year earlier, with a net margin of 19.2%.

Short interest was 8.2M shares at the Oct 15 settlement, down 2.9% from the prior report (6.2% of float, 5.5 days to cover).

Market cap$11.69B134.3M shares
Revenue · quarter$789.6M+5.9% YoY
Diluted EPS$1.10−26.2% YoY
P/E · TTM21.8×P/S 3.7×
Net margin19.2%Gross 69.4%
Dividend yieldNone
52-week range61.20 – 96.82−10.0% from high
Volume2.4M1.79× 20-day avg
Volatility · 60d34.9%Annualised
Short % of float6.2%5.5 days to cover
Net cash$595.1MCash $595.1M
Next earnings—Not scheduled
Split-adjusted performance
1W +7.2%1M +14.0%3M +7.4%6M −2.4%YTD −0.2%1Y +42.3%3Y +91.1%5Y +13.0%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum51
Revenue growth43
Net margin89
Value (low P/E)63
Size89

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →
Shares short8.2M−2.9% vs prior
Days to cover5.5Settled Oct 15
% of float6.2%
Short vol. 10d66.8%of daily volume

Closest peers by size in Surgical Instruments

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
GMEDGLOBUS MEDICAL$87.10+9.45%−2.4%+5.9%19.2%21.8$11.69B
PODDInsulet$165.02+6.56%+9.1%+23.5%11.8%30.5$11.44BCompare
PENPenumbra$322.45+0.76%−0.5%+15.6%10.3%80.9$12.71BCompare
BAXBaxter International$26.50+3.96%+56.1%+5.0%9.9%—$13.71BCompare
GKOSGlaukos$246.70+5.86%+82.4%+58.0%1.0%—$14.60BCompare
SOLVSolventum$89.35+5.42%+25.9%+2.2%4.2%10.6$15.21BCompare
TFXTeleflex Incorporated$149.87+7.09%+21.6%+28.9%17.5%—$6.35BCompare
HAEHaemonetics$127.42+5.94%+141.9%+5.6%9.7%60.2$5.80BCompare
MMSIMerit Medical Systems$90.63+7.69%+47.1%+8.4%10.2%33.9$5.43BCompare

News about GLOBUS MEDICAL

All news →
GMED vs. AXGN: Which Stock Should Value Investors Buy Now?Zacks Investment Research · 2d ago▲ PositiveWall Street Analysts Think Globus Medical (GMED) Could Surge 30.52%: Read This Before Placing a BetZacks Investment Research · 2d ago▲ PositiveWhy Globus Medical (GMED) is a Top Momentum Stock for the Long-TermZacks Investment Research · 2d ago▲ PositiveGMED or AXGN: Which Is the Better Value Stock Right Now?Zacks Investment Research · Oct 16, 2026▲ PositiveReasons to Add Globus Medical Stock to Your Portfolio NowZacks Investment Research · Oct 7, 2026▲ Positive

Quick answers

What does GLOBUS MEDICAL do?
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities.
What is GMED's market cap?
$11.69B, based on the Nov 4 close of $87.10.
What is GMED's P/E ratio?
21.8× trailing-twelve-month earnings of $535.43M.
Does GLOBUS MEDICAL pay a dividend?
No regular cash dividend has been paid in the last year.
How much of GMED is sold short?
8.2M shares, 6.2% of float, as of Oct 15, 2026.
What sector is GMED in?
Healthcare, in the Surgical Instruments industry.

About GLOBUS MEDICAL

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.

HQ: Audubon, PA6,000 employeesListed Aug 3, 2012globusmedical.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology